Stock listing
Medite Cancer Diagnostics Inc
Selected listing: MDIT · OTC · USD · US
Medite Cancer Diagnostics Inc (OTC:MDIT), Health Technology. Latest release Nov 15, 2017: MEDITE Cancer Diagnostics Appoints Joel Kanter To Its Board…
- Ticker
- OTC:MDIT
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- OTC
- Currency
- USD
About Medite Cancer Diagnostics Inc
Medite Cancer Diagnostics Inc (MDIT) is a public company operating in the American market, specializing in cancer diagnostic solutions. The company aims to enhance patient outcomes through its advanced diagnostic products and services.
Latest news from Medite Cancer Diagnostics Inc
MEDITE Cancer Diagnostics Appoints Joel Kanter To Its Board As An Independent Director
November 15, 2017
MEDITE Cancer Diagnostics Reports 2017 Third Quarter Financial Results
November 14, 2017
MEDITE Cancer Diagnostics Reports Appointments of New Chairman of the Board and Chief Executive Officer
November 8, 2017
MEDITE Cancer Diagnostics Reports Closing of $5.4 Million Private Financing, Providing Working Capital to Drive Commercial Plan Execution
October 3, 2017
MEDITE Cancer Diagnostics Reports 2017 Second Quarter and First Six Month Financial Results
August 14, 2017
Research Medite Cancer Diagnostics Inc
Medite Cancer Diagnostics Inc company profile
View the public company page for Medite Cancer Diagnostics Inc on 6ix.
Medite Cancer Diagnostics Inc news
Read company news and market updates connected to Medite Cancer Diagnostics Inc.
Medite Cancer Diagnostics Inc investor events
Find investor webinars, events, and replay context for Medite Cancer Diagnostics Inc.